NASDAQ:INDP | Free Cash Flow | Indaptus Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$7.01M
2025-12-31-$3.19M
2025-03-31-$5.05M
2024-12-31-$3.4M
2024-03-31-$3.94M
2023-12-31-$2.6M
2023-03-31-$4.96M
2022-12-31-$2.21M
2022-03-31-$3.12M
2021-12-31-$3.54M$0.00-$3.54M
2021-03-31-$825,584.00
2020-12-31-$957,030.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$14.82M
2024-12-31-$12.32M
2023-12-31-$13.41M
2022-12-31-$13.08M
2021-12-31-$11.29M$3,854.00-$11.29M
2020-12-31-$3.32M